Paget's disease of bone

Clinical Biochemistry

Volumn 45, Issue 1-2, 2012, Pages 43-48

  Cundy, Tim ^a   Reid, Ian R ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Bisphosphonates; Bone turnover markers; Epidemiology; Genetics biochemistry; Paget's disease of bone

Indexed keywords

ALKALINE PHOSPHATASE; BIOCHEMICAL MARKER; BISPHOSPHONIC ACID DERIVATIVE; PROCOLLAGEN; PROCOLLAGEN 1 N PEPTIDE; RISEDRONIC ACID; UNCLASSIFIED DRUG;

ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BIOCHEMISTRY; BONE TURNOVER; DISEASE SEVERITY; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; GENE LOCUS; GENE MUTATION; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC SUSCEPTIBILITY; HUMAN; PAGET BONE DISEASE; PARAMYXOVIRUS; PRIORITY JOURNAL; REMISSION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ALKALINE PHOSPHATASE; DIPHOSPHONATES; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MODELS, GENETIC; MUTATION; OSTEITIS DEFORMANS; PARAMYXOVIRIDAE; PEPTIDE FRAGMENTS; PROCOLLAGEN; RECURRENCE; REMISSION INDUCTION; TIME FACTORS; TREATMENT OUTCOME;

EID: 84855328372     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2011.09.026     Document Type: Article

References (43)

1. Kanis J.A. Pathophysiology and treatment of Paget's disease of bone 1991, Martin Dunitz Ltd, London.
2. Seitz S., Priemel M., Zustin J., Beil F.T., Semler J., Minne H., Schinke T., Amling M. Paget's disease of bone: histologic analysis of 754 patients. J Bone Miner Res 2009, 24:62-69.
3. Reid I.R., Nicholson G.C., Weinstein R.S., Hosking D.J., Cundy T., Kotowicz M.A., Murphy W.A., Yeap S., Dufresne S., Lombardi A., Musliner T.A., Thompson D.E., Yates A.J. Biochemical and radiologic improvement in Paget's disease of bone treated with alendronate: a randomized, placebo-controlled trial. Am J Med 1996, 101:341-348.
4. Kukita A., Chenu C., McManus L.M., Mundy G.R., Roodman G.D. Atypical multinucleated cells for in long-term marrow cultures from patients with Paget's disease. J Clin Invest 1990, 85:1280-1286.
5. Menaa C., Barsony J., Reddy S.V., Cornish J., Cundy T., Roodman G.D. 1,25-dihydroxyvitamin D-3 hypersensitivity of osteoclast precursors from patients with Paget's disease. J Bone Miner Res 2000, 15:228-236.
6. Menaa C., Reddy S.V., Kurihata N., Cornish J., Cundy T., Roodman G.D. Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone. J Clin Invest 2000, 105:1833-1838.
7. Naot D., Bava U., Matthews B., Gamble G.D., Black M., Song S., Pitto R.P., Cundy T., Cornish J. Reid IR differential gene expression in cultured osteoblasts and bone marrow stromal cells from patients with Paget's disease of bone. J Bone Miner Res 2007, 22:298-309.
8. Haddaway M.J., Davie M.W.J., McCall I.W., Howdle S. Effect of age and gender on the number and distribution of sites in Paget's disease of bone. Br J Radiol 2007, 80:532-536.
9. Cundy T., Bolland M. Paget disease of bone. Trends Endocrinol Metab 2008, 19:246-253.
10. Renier J.C., Audran M. Progression in length and width of pagetic lesions, and estimation of age at disease onset. Rev Rhum Ed Fr 1997, 64:35-43.
11. Mays S. Archaeological skeletons support a northwest European origin for Paget's disease of bone. J Bone Miner Res 2010, 25:1839-1841.
12. Barker D.J.P. The epidemiology of Paget's disease of bone. Br Med Bull 1984, 40:396-400.
13. Gardner M.J., Guyer P.B., Barker D.J.P. Paget's disease of bone among British migrants to Australia. Br Med J 1978, 2:1436-1437.
14. Cooper C., Schafheutle K., Dennison E., Kellingray S., Guyer P., Barker D. The epidemiology of Paget's disease in Britain: is the prevalence decreasing?. J Bone Miner Res 1999, 14:192-197.
15. Doyle T., Gunn J., Anderson G., Gill M., Cundy T. Paget's disease in New Zealand: evidence for declining prevalence. Bone 2002, 31:616-619.
16. Poor G., Donath J., Fornet B., Cooper C. Epidemiology of Paget's disease in Europe: the prevalence is decreasing. J Bone Miner Res 2006, 21:1545-1549.
17. Cundy H.R., Gamble G., Wattie D., Rutland M., Cundy T. Paget's disease of bone in New Zealand: continued decline in disease severity. Calcif Tissue Int 2004, 75:358-364.
18. Merlotti D., Gennari L., Galli B., Martini G., Calabrò A., De Paola V., Ceccarelli C., Nardi P., Annalisa Avanzati A., Nuti R. Characteristics and familial aggregation of Paget's disease of bone in Italy. J Bone Miner Res 2005, 20:1356-1364.
19. Lopez-Abente G., Morales-Piga A., Elena-Ibanez A., Rey-Rey J.S., Corres-Gonzalez J. Cattle, pets, and Paget's disease of bone. Epidemiology 1997, 8:247-251.
20. Laurin N., Brown J.P., Morissette J., Raymond V. Recurrent mutation of the gene encoding sequestosome 1 (SQSTM1/p62) in Paget disease of bone. Am J Hum Genet 2002, 70:1582-1588.
21. Hocking L.J., Lucas G.J.A., Daroszewska A., Bennett S.T., Mangion J., Cundy T., Nicholson G.C., Gutteridge D.H., Wuyts W., Van Hul W., Ralston S.H. Domain-specific mutations in sequestosome 1 (SQSTM1) cause familial and sporadic Paget's disease. Hum Mol Genet 2002, 11:2735-2739.
22. Hocking L.J., Lucas G.J.A., Daroszewska A., Cundy T., Nicholson G.C., Donath J., Walsh J., Findlayson C., Cavey J.R., Ciani B., Sheppard P.W., Searle M.S., Layfield R., Ralston S.H. Novel UBA domain mutations of SQSTM1 in Paget's disease of bone: genotype phenotype correlation, functional analysis, and structural consequences. J Bone Miner Res 2004, 19:1122-1127.
23. Chung P.Y.J., Beyens G., Guañabens N., Boonen S., Papapoulos S., Karperien M., Eekhoff M., Van Wesenbeeck L., Jennes K., Geusens P., Offeciers E., Van Offel J., Westhovens R., Zmierczak H., Devogelaer J.P., Van Hul W. Founder effect in different European countries for the recurrent P392L SQSTM1 mutation in Paget's disease of bone. Calcif Tissue Int 2008, 83:34-42.
24. Bolland M.J., Tong P.C., Naot D., Callon K.E., Rutland M.D., Cundy T. Delayed development of Paget's disease in offspring inheriting SQSTM1 mutations. J Bone Miner Res 2007, 22:411-415.
25. Kimonis V.E., Mehta S.G., Fulchiero E.C., Thomasova D., Pasquali M., Boycott K., Neilan E.G., Kartashov A., Forman M.S., Tucker S., Kimonis K., Mumm S., Whyte M.P., Smith C.D., Watts G.D.J. Clinical studies in familial VCP myopathy associated with Paget disease of bone and frontotemporal dementia. Am J Med Genet 2008, 146A:745-757.
26. Albagha O.M.E., Visconti M.R., Alonso N., Langston A.L., Cundy T., Dargie R., Dunlop M.G., Fraser W.D., Hooper M.J., Nicholson G.C., Del Pinto J., Gonzalez-Sarmiento R., Di Stefano M., Tenesa A., Walsh J.P., Ralston S.H. Genome wide association study identifies variants at the CSF1, OPTN and TNFRSF11A loci as genetic risk factors for Paget's disease of bone. Nat Genet 2010, 42:520-524.
27. Chung J.P.Y., Beyens G., Boonen S., Papapoulos S., Geusens P., Karperien M., Vanhoenacker F., Verbruggen L., Fransen E., Van Offel J., Goemaere S., Zmierczak H.G., Westhovens R., Devogelaer J.P., Van Hul W. The majority of genetic risk for Paget's disease of bone is explained by genetic variants close to the CSF1, OPTN, TM7SF4, and TNFRSF11A genes. Hum Genet 2010, 128:615-626.
28. Albagha O.M.E., Wani S., Visconti M.R., Alonso N., Goodman K., Brandi M.L., Cundy T., Chung P.Y.J., Dargie R., Devogelaer J.P., Falchetti A., Fraser W.D., Gennari L., Gianfresco F., Hooper M.J., Van Hul W., Isia G., Nicholson G.C., Nuti R., Papapoulos S., Del Pinto Montes J., Ratajczak T., Rea S.L., Rendina D., Gonzalez-Sarmiento R., Di Stefano M., Ward L.C., Walsh J.P., Ralston S.H. Genome wide association identifies three new susceptibility loci for Paget's disease of bone. Nat Genet 2011, 43:685-689.
29. Chung J.P.Y., Beyens G., De Freitas F., Boonen S., Geusens P., Vanhoenacker F., Verbruggen L., Van Offel J., Goemaere S., Zmierczak H.G., Westhovens R., Devogelaer J.P., Van Hul W. Indications for a genetic association of a VCP polymorphism with the pathogenesis of sporadic Paget's disease of bone, but not for TNFSF11 (RANKL) and IL-6 polymorphisms. Mol Gen Metab 2011, 10.1016/j.ymgme.2011.03.021.
30. Ralston S.H. Juvenile Paget's disease, familial expansile osteolysis and other genetic osteolytic disorders. Best Pract Res Clin Rheumatol 2008, 22(1):101-111.
31. Kerr N.M., Cassinelli H., Di Meglio L., Tau C., Tüyzüs B., Cundy T., Vincent A.L. Ocular manifestations of juvenile Paget disease. Arch Ophthalmol 2010, 128:698-703.
32. Friedrichs W.E., Reddy S.V., Bruder J.M., Cundy T., Cornish J., Singer F.R., Roodman G.D. Sequence analysis of measles virus nucleocapsid transcripts in patients with Paget's disease. J Bone Miner Res 2002, 17:145-151.
33. Mee A.P., Dixon J.A., Hoyland J.A., Davies M., Selby P.L., Mawer E.B. Detection of canine distemper virus in 100% of Paget's disease samples by in situ reverse transcriptase-polymerase chain reaction. Bone 1988, 23:171-175.
34. Ralston S.H., Afzal M.A., Helfrich M.H., Fraser W.D., Gallagher J.A., Mee A., Rima B. Multicenter blinded analysis of RT-PCR detection methods for paramyxoviruses in relation to Paget's disease of bone. J Bone Miner Res 2007, 22:569-577.
35. Matthews B.G., Afzal M.A., Minor P.D., Bava U., Callon K.E., Pitto R.P., Cundy T., Cornish J., Reid I.R., Naot D. Failure to detect measles virus RNA in bone cells from patients with Paget's disease. J Clin Endocrinol Metab 2008, 93:1398-1401.
36. Van Staa T.P., Selby P., Leufkens H.G., Lyles K., Sprafka J.M., Cooper C. Incidence and natural history of Paget's disease of bone in England and Wales. J Bone Miner Res 2002, 17:465-471.
37. Langston A.L., Campbell M.K., Fraser W.D., Maclennan G., Selby P., Ralston S.H. Clinical determinants of quality of life in Paget's disease of bone. Calcif Tissue Int 2007, 80:1-9.
38. Shankar S., Hosking D.J. Biochemical assessment of Paget's disease of bone. J Bone Miner Res 2006, 21(Suppl 2):P22-P27.
39. Reid I.R., Davidson J.S., Wattie D., Wu F., Lucas J., Gamble G.D., Rutland M.D., Cundy T. Comparative responses of bone turnover markers to bisphosphonate therapy in Paget's disease of bone. Bone 2004, 35:224-230.
40. Reid I.R., Miller P., Lyles K., Fraser W., Brown J.P., Saidi Y., Mesenbrink P., Su G., Pak J., Zelenakas K., Luchi M., Richardson P., Hosking D. Comparison of a single infusion of zoledronic acid with risedronate for Paget's disease. N Eng J Med 2005, 353:898-908.
41. Reid IR, Lyles K, Su G, Brown JP, Walsh JP, Del Pino-Montes J, Miller PD, Fraser WD, Cafoncelli S, Bucci-Rechtweg C, Hosking DJ. A single infusion of zoledronic acid produces sustained remissions in Paget's disease: data to 6.5 years. J Bone Miner Res 2011;26:2261-70.
42. Langston A.L., Campbell M.K., Fraser W.D., MacLennan G.S., Selby P.L., Ralston S.H. Randomised trial of intensive bisphosphonate treatment versus symptomatic management in Paget's disease of bone. J Bone Miner Res 2010, 25:20-31. for the PRISM Trial Group.
43. Matthews B., Cundy T. Paget's disease of bone. Expert Rev Endocrinol Metab 2009, 4:651-668.